Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
Drug Science and University College London (UCL) announced a strategic partnership to advance research into MDMA-assisted psychotherapy. This collaboration aims to refine our understanding of how MDMA works in conjunction with psychotherapeutic treatments, addressing concerns that the “psychotherapy” component may not be fully optimized.
MDMA-assisted psychotherapy has shown promise in treating various mental health conditions, but as Professor David Nutt, founder of Drug Science, noted, “MDMA-assisted therapy has shown great promise, but the recent decision by the FDA highlights the necessity for further research.” As Drug Science stated, the collaboration with UCL seeks to answer these calls for more in-depth exploration of the therapy’s psychotherapeutic elements.
Enhancing MDMA-Assisted Therapy
The collaboration between Drug Science and UCL will focus on dissecting the complex relationship between MDMA and various psychotherapeutic approaches. According to Prof. Sunjeev Kamboj, Professor of Translational Clinical Psychology at UCL, “We’re at an impasse in understanding how these drugs work at a high level. This is why we are taking …